
1. plos one. 2020 may 7;15(5):e0232183. doi: 10.1371/journal.pone.0232183.
ecollection 2020.

a genetically hmgb2 attenuated blood stage p. berghei induces crossed-long live
protection.

briquet s(1)(2)(3), lawson-hogban n(1)(2)(3), peronet r(4)(5), mécheri s(4)(5),
vaquero c(1)(2)(3).

author information: 
(1)sorbonne université, centre d'immunologie et des maladies infectieuses
(cimi-paris), paris, france.
(2)inserm, u1135, cimi-paris, paris, france.
(3)cnrs, erl 8255, cimi-paris, paris, france.
(4)unité de biologie et génétique du paludisme, institut pasteur, paris, france.
(5)centre national de recherche scientifique ou cnrs, unité de recherche associée
2581, paris, france.

due lack efficiency control malaria elicited sub-unit vaccine
preparations, vaccination live-attenuated plasmodium parasite reported 70
years ago irradiated sporozoites regained recently significant interest.
the complex life cycle parasite different stages development
between mammal host anopheles help propose easy vaccine
strategy. order achieve complete long-lasting protection against
plasmodium infection disease, considered genetically attenuated blood
stage parasite hmgb2 gene coding high-mobility-group-box 2
(hmgb2). plasmodium protein belongs hmgb family hold the
mammal proteins, double life since acts first nuclear factor involved
in chromatin remodelling transcription regulation second, secreted
as active pro-inflammatory alarmin protein. even though number reports 
on whole living attenuated blood stage parasites limited compared to
attenuated sporozoites, results reported plasmodium ko parasites are
very encouraging. report, present novel strategy based on
pre-immunization δhmgb2pbnk65 parasitized red blood cells confer
long-lasting protection murine experimental cerebral malaria model against
two highly pathogenic homologous heterologous parasites.

doi: 10.1371/journal.pone.0232183 
pmcid: pmc7205229
pmid: 32379764  [indexed medline]

conflict interest statement: authors declared competing
interests exist.

